The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.

Some elderly cancer patients, even with good Eastern Cooperative Oncology Group performance status (ECOG-PS), have poor survival outcomes and cannot tolerate standard therapy. Few studies have detailed the associations between the G8 screening tool, ECOG-PS, and overall survival (OS) in such patient...

Full description

Bibliographic Details
Main Authors: Masahiro Takahashi, Masanobu Takahashi, Keigo Komine, Hideharu Yamada, Yuki Kasahara, Sonoko Chikamatsu, Akira Okita, Shukuei Ito, Kota Ouchi, Yoshinari Okada, Hiroo Imai, Ken Saijo, Hidekazu Shirota, Shin Takahashi, Takahiro Mori, Hideki Shimodaira, Chikashi Ishioka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5480957?pdf=render
_version_ 1819181731306012672
author Masahiro Takahashi
Masanobu Takahashi
Keigo Komine
Hideharu Yamada
Yuki Kasahara
Sonoko Chikamatsu
Akira Okita
Shukuei Ito
Kota Ouchi
Yoshinari Okada
Hiroo Imai
Ken Saijo
Hidekazu Shirota
Shin Takahashi
Takahiro Mori
Hideki Shimodaira
Chikashi Ishioka
author_facet Masahiro Takahashi
Masanobu Takahashi
Keigo Komine
Hideharu Yamada
Yuki Kasahara
Sonoko Chikamatsu
Akira Okita
Shukuei Ito
Kota Ouchi
Yoshinari Okada
Hiroo Imai
Ken Saijo
Hidekazu Shirota
Shin Takahashi
Takahiro Mori
Hideki Shimodaira
Chikashi Ishioka
author_sort Masahiro Takahashi
collection DOAJ
description Some elderly cancer patients, even with good Eastern Cooperative Oncology Group performance status (ECOG-PS), have poor survival outcomes and cannot tolerate standard therapy. Few studies have detailed the associations between the G8 screening tool, ECOG-PS, and overall survival (OS) in such patients.Cancer patients, aged 70 years or older, were assessed for G8 and classified into three groups according to their G8 score: <11 as the low score group, 11-14 as the intermediate score group, and >14 as the high score group. We retrospectively analyzed the association between G8 score and OS in all patients and for each ECOG-PS-categorized group.Out of 264 enrolled patients, most patients (87%) with solid tumor were categorized as TNM stage IV. ECOG-PS was 0 or 1 in 215 patients and ≥2 in 48; there was missing data for one patient. Among all patients, the low score group with a median OS of 7.7 months survived significantly less than both the high score group with a median OS of 25.6 months [Hazard ratio (HR) 3.48; 95% confidence interval (CI), 1.96-6.63; p < 0.0001] and the intermediate score group with a median of 15.6 months (HR 1.83; 95% CI, 1.28-2.65; p < 0.001). In the multivariate analysis, TNM stage and G8 score were independent prognostic factors for OS. When patients with an ECOG-PS of 0 or 1 were analyzed, patients with a lower G8 score showed significantly shorter OS than patients with a higher score when any two groups were compared.This novel classification of the G8 score contributes to prompt identification of patients with poor prognosis and improved the prognostic value of ECOG-PS. Using G8 with ECOG-PS may be helpful in deciding treatment for elderly patients with advanced cancer.
first_indexed 2024-12-22T22:34:54Z
format Article
id doaj.art-7428c8e7332240c4aa5164edec14e8a0
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T22:34:54Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7428c8e7332240c4aa5164edec14e8a02022-12-21T18:10:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017969410.1371/journal.pone.0179694The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.Masahiro TakahashiMasanobu TakahashiKeigo KomineHideharu YamadaYuki KasaharaSonoko ChikamatsuAkira OkitaShukuei ItoKota OuchiYoshinari OkadaHiroo ImaiKen SaijoHidekazu ShirotaShin TakahashiTakahiro MoriHideki ShimodairaChikashi IshiokaSome elderly cancer patients, even with good Eastern Cooperative Oncology Group performance status (ECOG-PS), have poor survival outcomes and cannot tolerate standard therapy. Few studies have detailed the associations between the G8 screening tool, ECOG-PS, and overall survival (OS) in such patients.Cancer patients, aged 70 years or older, were assessed for G8 and classified into three groups according to their G8 score: <11 as the low score group, 11-14 as the intermediate score group, and >14 as the high score group. We retrospectively analyzed the association between G8 score and OS in all patients and for each ECOG-PS-categorized group.Out of 264 enrolled patients, most patients (87%) with solid tumor were categorized as TNM stage IV. ECOG-PS was 0 or 1 in 215 patients and ≥2 in 48; there was missing data for one patient. Among all patients, the low score group with a median OS of 7.7 months survived significantly less than both the high score group with a median OS of 25.6 months [Hazard ratio (HR) 3.48; 95% confidence interval (CI), 1.96-6.63; p < 0.0001] and the intermediate score group with a median of 15.6 months (HR 1.83; 95% CI, 1.28-2.65; p < 0.001). In the multivariate analysis, TNM stage and G8 score were independent prognostic factors for OS. When patients with an ECOG-PS of 0 or 1 were analyzed, patients with a lower G8 score showed significantly shorter OS than patients with a higher score when any two groups were compared.This novel classification of the G8 score contributes to prompt identification of patients with poor prognosis and improved the prognostic value of ECOG-PS. Using G8 with ECOG-PS may be helpful in deciding treatment for elderly patients with advanced cancer.http://europepmc.org/articles/PMC5480957?pdf=render
spellingShingle Masahiro Takahashi
Masanobu Takahashi
Keigo Komine
Hideharu Yamada
Yuki Kasahara
Sonoko Chikamatsu
Akira Okita
Shukuei Ito
Kota Ouchi
Yoshinari Okada
Hiroo Imai
Ken Saijo
Hidekazu Shirota
Shin Takahashi
Takahiro Mori
Hideki Shimodaira
Chikashi Ishioka
The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
PLoS ONE
title The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
title_full The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
title_fullStr The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
title_full_unstemmed The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
title_short The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
title_sort g8 screening tool enhances prognostic value to ecog performance status in elderly cancer patients a retrospective single institutional study
url http://europepmc.org/articles/PMC5480957?pdf=render
work_keys_str_mv AT masahirotakahashi theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT masanobutakahashi theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT keigokomine theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hideharuyamada theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT yukikasahara theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT sonokochikamatsu theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT akiraokita theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT shukueiito theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT kotaouchi theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT yoshinariokada theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hirooimai theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT kensaijo theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hidekazushirota theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT shintakahashi theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT takahiromori theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hidekishimodaira theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT chikashiishioka theg8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT masahirotakahashi g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT masanobutakahashi g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT keigokomine g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hideharuyamada g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT yukikasahara g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT sonokochikamatsu g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT akiraokita g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT shukueiito g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT kotaouchi g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT yoshinariokada g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hirooimai g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT kensaijo g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hidekazushirota g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT shintakahashi g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT takahiromori g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT hidekishimodaira g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy
AT chikashiishioka g8screeningtoolenhancesprognosticvaluetoecogperformancestatusinelderlycancerpatientsaretrospectivesingleinstitutionalstudy